Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 2
1995 3
1996 1
1998 1
1999 3
2000 2
2003 1
2004 5
2005 4
2006 6
2007 2
2008 4
2009 4
2010 3
2011 8
2012 6
2013 8
2014 12
2015 16
2016 7
2017 11
2018 6
2019 5
2020 2
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 15479434

112 results
Results by year
Filters applied: . Clear all
Page 1
Vaccine adjuvants: current state and future trends.
Petrovsky N, Aguilar JC. Petrovsky N, et al. Immunol Cell Biol. 2004 Oct;82(5):488-96. doi: 10.1111/j.0818-9641.2004.01272.x. Immunol Cell Biol. 2004. PMID: 15479434 Review.
Adjuvants and autoimmunity.
Israeli E, Agmon-Levin N, Blank M, Shoenfeld Y. Israeli E, et al. Lupus. 2009 Nov;18(13):1217-25. doi: 10.1177/0961203309345724. Lupus. 2009. PMID: 19880572 Review.
Aluminium compounds for use in vaccines.
Lindblad EB. Lindblad EB. Immunol Cell Biol. 2004 Oct;82(5):497-505. doi: 10.1111/j.0818-9641.2004.01286.x. Immunol Cell Biol. 2004. PMID: 15479435 Review.
Evaluation of recombinant Onchocerca volvulus activation associated protein-1 (ASP-1) as a potent Th1-biased adjuvant with a panel of protein or peptide-based antigens and commercial inactivated vaccines.
Xiao W, Du L, Liang C, Guan J, Jiang S, Lustigman S, He Y, Zhou Y. Xiao W, et al. Vaccine. 2008 Sep 15;26(39):5022-9. doi: 10.1016/j.vaccine.2008.07.028. Epub 2008 Aug 19. Vaccine. 2008. PMID: 18675867 Free PMC article.
112 results
Jump to page
Feedback